Codelivery of envelope protein in alum with MVA vaccine induces CXCR3- biased CXCR5+ and CXCR5- CD4 T cell responses in rhesus macaques

Journal of Immunology

Volumn 195, Issue 3, 2015, Pages 994-1005

  Iyer, Smita S ^a   Gangadhara, Sailaja ^a   Victor, Blandine ^a   Gomez, Rosy ^a   Basu, Rahul ^a   Hong, Jung Joo ^a   Labranche, Celia ^b   Montefiori, David C ^b   Villinger, Francois ^a   Moss, Bernard ^c   Amara, Rama Rao ^a,d  

^a EMORY UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; DNA VACCINE; GLYCOPROTEIN GP 140; INDUCIBLE T CELL COSTIMULATOR LIGAND; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN BCL 6; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; ALUMINUM POTASSIUM SULFATE; ALUMINUM SULFATE; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN; IMMUNOLOGICAL ADJUVANT; INDUCIBLE T CELL COSTIMULATOR; MVA VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; GERMINAL CENTER; HERPES SIMPLEX VIRUS 251; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; LONGEVITY; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TH1 CELL; VIREMIA; VIRUS LOAD; VIRUS NEUTRALIZATION; ANIMAL; BIOSYNTHESIS; BLOOD; CYTOLOGY; HELPER CELL; IMMUNOLOGY; VACCINATION; VETERINARY; VIROLOGY;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIBODIES, VIRAL; GLYCOPROTEINS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; LYMPH NODES; MACACA MULATTA; MALE; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, CCR5; RECEPTORS, CXCR3; RECEPTORS, CXCR5; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; VIRAL VACCINES; VIREMIA;

EID: 84937711740     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500083     Document Type: Article

References (34)

1. Slifka, M. K., M. Matloubian, and R. Ahmed. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69: 1895-1902.
2. Chan, T. D., D. Gatto, K. Wood, T. Camidge, A. Basten, and R. Brink. 2009. Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts. J. Immunol. 183: 3139-3149.
3. Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29: 621-663.
4. Cyster, J. G. 2010. Shining a light on germinal center B cells. Cell 143: 503-505.
5. Pallikkuth, S., A. Parmigiani, S. Y. Silva, V. K. George, M. Fischl, R. Pahwa, and S. Pahwa. 2012. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood 120: 985-993.
6. He, J., L. M. Tsai, Y. A. Leong, X. Hu, C. S. Ma, N. Chevalier, X. Sun, K. Vandenberg, S. Rockman, Y. Ding, et al. 2013. Circulating precursor CCR7 (lo)PD-1(hi) CXCR5+ CD4+ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39: 770-781.
7. Morita, R., N. Schmitt, S. E. Bentebibel, R. Ranganathan, L. Bourdery, G. Zurawski, E. Foucat, M. Dullaers, S. Oh, N. Sabzghabaei, et al. 2011. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34: 108-121.
8. Bentebibel, S. E., S. Lopez, G. Obermoser, N. Schmitt, C. Mueller, C. Harrod, E. Flano, A. Mejias, R. A. Albrecht, D. Blankenship, et al. 2013. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci. Transl. Med. 5: 176ra132.
9. Locci, M., C. Havenar-Daughton, E. Landais, J. Wu, M. A. Kroenke, C. L. Arlehamn, L. F. Su, R. Cubas, M. M. Davis, A. Sette, et al. 2013. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIVantibody responses. Immunity 39: 758-769.
10. Kwa, S., L. Lai, S. Gangadhara, M. Siddiqui, V. B. Pillai, C. Labranche, T. Yu, B. Moss, D. C. Montefiori, H. L. Robinson, et al. 2014. CD40L-Adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge. J. Virol. 88: 9579-9589.
11. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, et al. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292: 69-74.
12. Van Rompay, K. K., J. L. Greenier, K. S. Cole, P. Earl, B. Moss, J. D. Steckbeck, B. Pahar, T. Rourke, R. C. Montelaro, D. R. Canfield, et al. 2003. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. J. Virol. 77: 179-190.
13. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286: 111-122.
14. Silveira, E. L., S. P. Kasturi, Y. Kovalenkov, A. U. Rasheed, P. Yeiser, Z. S. Jinnah, T. H. Legere, B. Pulendran, F. Villinger, and J. Wrammert. 2015. Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies. J. Immunol. Methods 416: 69-83.
15. Montefiori, D. C. 2005. Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr. Protoc. Immunol. 64: 12.11: 12.11.1-12.11.17.
16. Schaerli, P., K. Willimann, A. B. Lang, M. Lipp, P. Loetscher, and B. Moser. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192: 1553-1562.
17. Chtanova, T., S. G. Tangye, R. Newton, N. Frank, M. R. Hodge, M. S. Rolph, and C. R. Mackay. 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173: 68-78.
18. Yusuf, I., R. Kageyama, L. Monticelli, R. J. Johnston, D. Ditoro, K. Hansen, B. Barnett, and S. Crotty. 2010. Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150). J. Immunol. 185: 190-202.
19. Petrovas, C., T. Yamamoto, M. Y. Gerner, K. L. Boswell, K. Wloka, E. C. Smith, D. R. Ambrozak, N. G. Sandler, K. J. Timmer, X. Sun, et al. 2012. CD4 T follicular helper cell dynamics during SIV infection. J. Clin. Invest. 122: 3281-3294.
20. Haynes, N. M., C. D. Allen, R. Lesley, K. M. Ansel, N. Killeen, and J. G. Cyster. 2007. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-Associated subpopulation. J. Immunol. 179: 5099-5108.
21. Wrammert, J., K. Smith, J. Miller, W. A. Langley, K. Kokko, C. Larsen, N. Y. Zheng, I. Mays, L. Garman, C. Helms, et al. 2008. Rapid cloning of highaffinity human monoclonal antibodies against influenza virus. Nature 453: 667-671.
22. Wrammert, J., N. Onlamoon, R. S. Akondy, G. C. Perng, K. Polsrila, A. Chandele, M. Kwissa, B. Pulendran, P. C. Wilson, O. Wittawatmongkol, et al. 2012. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J. Virol. 86: 2911-2918.
23. Gosselin, A., P. Monteiro, N. Chomont, F. Diaz-Griffero, E. A. Said, S. Fonseca, V. Wacleche, M. El-Far, M. R. Boulassel, J. P. Routy, et al. 2010. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection. J. Immunol. 184: 1604-1616.
24. Haynes, B. F., and M. J. McElrath. 2013. Progress in HIV-1 vaccine development. Curr. Opin. HIV AIDS 8: 326-332.
25. Streeck, H., M. P. D'Souza, D. R. Littman, and S. Crotty. 2013. Harnessing CD4+ T cell responses in HIV vaccine development. Nat. Med. 19: 143-149.
26. Dai, P., W. Wang, H. Cao, F. Avogadri, L. Dai, I. Drexler, J. A. Joyce, X. D. Li, Z. Chen, T. Merghoub, et al. 2014. Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway. PLoS Pathog. 10: e1003989.
27. Teigler, J. E., S. Phogat, G. Franchini, V. M. Hirsch, N. L. Michael, and D. H. Barouch. 2014. The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys. J. Virol. 88: 1809-1814.
28. Mohr, E., A. F. Cunningham, K. M. Toellner, S. Bobat, R. E. Coughlan, R. A. Bird, I. C. MacLennan, and K. Serre. 2010. IFN-g produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine. Proc. Natl. Acad. Sci. USA 107: 17292-17297.
29. Serre, K., A. F. Cunningham, R. E. Coughlan, A. C. Lino, A. Rot, E. Hub, K. Moser, R. Manz, A. Ferraro, R. Bird, et al. 2012. CD8 T cells induce T-betdependent migration toward CXCR3 ligands by differentiated B cells produced during responses to alum-protein vaccines. Blood 120: 4552-4559.
30. Hale, J. S., B. Youngblood, D. R. Latner, A. U. Mohammed, L. Ye, R. S. Akondy, T. Wu, S. S. Iyer, and R. Ahmed. 2013. Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection. Immunity 38: 805-817.
31. Paiardini, M., B. Cervasi, E. Reyes-Aviles, L. Micci, A. M. Ortiz, A. Chahroudi, C. Vinton, S. N. Gordon, S. E. Bosinger, N. Francella, et al. 2011. Low levels of SIV infection in sooty mangabey central memory CD4+ T cells are associated with limited CCR5 expression. Nat. Med. 17: 830-836.
32. Pegu, P., M. Vaccari, S. Gordon, B. F. Keele, M. Doster, Y. Guan, G. Ferrari, R. Pal, M. G. Ferrari, S. Whitney, et al. 2013. Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV (mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial. J. Virol. 87: 1708-1719.
33. Buge, S. L., H. L. Ma, R. R. Amara, L. S. Wyatt, P. L. Earl, F. Villinger, D. C. Montefiori, S. I. Staprans, Y. Xu, E. Carter, et al. 2003. Gp120-Alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge. AIDS Res. Human Retro. 19: 891-900.
34. Earl, P. L., L. S. Wyatt, D. C. Montefiori, M. Bilska, R. Woodward, P. D. Markham, J. D. Malley, T. U. Vogel, T. M. Allen, D. I. Watkins, et al. 2002. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model. Virology 294: 270-281.